Check out our most popular compounded medications! Get Started
Perphenazine 0.5 mg/mL Oral Suspension is a liquid dosage form where perphenazine is uniformly dispersed in a liquid medium, ensuring a homogeneous mixture for precise administration. This formulation is primarily used to treat schizophrenia and severe nausea and vomiting.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Perphenazine 0.5 mg/mL Oral Suspension is a compounded medication formulated to deliver precise dosing for patients requiring perphenazine in a liquid form. As a liquid dosage form, it provides a homogeneous mixture where the active ingredient is uniformly dispersed throughout the liquid medium, ensuring consistent dosing with each administration.
Perphenazine is a typical antipsychotic medication belonging to the phenothiazine class. It works primarily by blocking dopamine receptors in the brain, which helps to reduce symptoms of psychosis such as hallucinations
Perphenazine 0.5 mg/mL Oral Suspension is a liquid dosage form designed to provide a homogeneous mixture for administration, ensuring consistent dosing and ease of use. This formulation is primarily used in the management of psychiatric disorders such as schizophrenia and severe nausea and vomiting. As with any medication, it is crucial to be aware of potential drug interactions that may affect the efficacy and safety of perphenazine.
Perphenazine is a typical antipsychotic that works by blocking dopamine receptors in the brain, which can help alleviate symptoms of psychosis. However, this mechanism of action also predisposes it to interact with other medications that affect the central nervous system. Patients and prescribers should be particularly cautious when perphenazine is used concomitantly with other CNS depressants, such as benzodiazepines, opioids, or alcohol, as these combinations can lead to enhanced sedative effects, respiratory depression, and increased risk of overdose.
Additionally, perphenazine may interact with medications that influence the cytochrome P450 enzyme system, particularly CYP2D6. Drugs that inhibit CYP2D6, such as fluoxetine, paroxetine, and quinidine, can increase perphenazine plasma levels, potentially leading to enhanced side effects such as extrapyramidal symptoms, tardive dyskinesia, and neuroleptic malignant syndrome. Conversely, inducers of this enzyme, like rifampin and carbamazepine, may decrease perphenazine levels, reducing its therapeutic efficacy.
Patients taking antihypertensive medications should be monitored closely, as perphenazine can potentiate the hypotensive effects of these drugs, leading to dizziness, fainting, or falls. Similarly, caution is advised when perphenazine is administered with anticholinergic agents, as this combination can exacerbate anticholinergic side effects such as dry mouth, constipation, urinary retention, and blurred vision.
Furthermore, perphenazine may interact with medications that prolong the QT interval, such as certain antiarrhythmics, antibiotics, and other antipsychotics. This can increase the risk of serious cardiac arrhythmias, including torsades de pointes. Regular monitoring of cardiac function and electrolyte levels is recommended when these drugs are used together.
Patients and prescribers should also be aware of the potential for perphenazine to interact with medications that affect blood glucose levels, as it may alter glucose metabolism and necessitate adjustments in the dosing of antidiabetic agents. Additionally, perphenazine can interfere with the action of anticoagulants, requiring careful monitoring of coagulation parameters to avoid bleeding complications.
It is essential for patients to inform their healthcare providers of all medications they are taking, including over-the-counter drugs and supplements, to ensure safe and appropriate use of perphenazine. If you have any questions or concerns about drug interactions with perphenazine 0.5 mg/mL Oral Suspension, please reach out to us at Bayview Pharmacy for further guidance and support.
Perphenazine 0.5 mg/mL Oral Suspension is a liquid dosage form designed to deliver the antipsychotic medication perphenazine in a manner that ensures uniform distribution of the active ingredient throughout the liquid medium. This formulation is particularly beneficial for patients who may have difficulty swallowing tablets or capsules, providing an alternative that is easier to ingest and allows for precise dosing adjustments. The suspension is carefully compounded to maintain a homogeneous mixture, ensuring that each milliliter of the suspension contains an exact concentration of perphenazine, thereby facilitating accurate dosing and consistent therapeutic effects.
Perphenazine is a typical antipsychotic medication that belongs to the class of drugs known as phenothiazines. It works primarily by modulating the activity of neurotransmitters in the brain, particularly dopamine. By blocking dopamine receptors, perphenazine helps to reduce the overactivity of dopamine pathways that are often associated with symptoms of psychotic disorders. This mechanism of action is crucial in managing conditions such as schizophrenia and severe nausea or vomiting, where dopamine dysregulation plays a significant role.
In the treatment of schizophrenia, perphenazine helps alleviate symptoms such as hallucinations, delusions, and thought disorders by stabilizing the chemical imbalances in the brain. For patients experiencing severe nausea and vomiting, perphenazine acts on the chemoreceptor trigger zone in the brain, reducing the sensation of nausea and the reflex to vomit. The oral suspension form allows for flexible dosing, which can be particularly advantageous in titrating the dose to achieve optimal therapeutic outcomes while minimizing potential side effects.
For prescribers, the perphenazine oral suspension offers a customizable approach to treatment, allowing for dose adjustments based on the patient's response and tolerance. This flexibility is essential in managing the delicate balance between efficacy and side effects, which can vary significantly among individuals. The liquid form also facilitates administration in patients with swallowing difficulties or those who require enteral feeding, ensuring that they receive the necessary medication without compromising their treatment regimen.
Patients using perphenazine oral suspension should be aware of the importance of following the prescribed dosing schedule and using the provided measuring device to ensure accurate dosing. It is also crucial to shake the suspension well before each use to maintain the uniform distribution of the active ingredient. As with any medication, adherence to the prescribed regimen and regular communication with healthcare providers are key to achieving the best possible outcomes.
If you have any questions or require further information about Perphenazine 0.5 mg/mL Oral Suspension, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any inquiries or concerns you may have regarding this formulation or its use in treating specific disease states.
Perphenazine 0.5 mg/mL Oral Suspension is a liquid dosage form where the active ingredient, perphenazine, is uniformly dispersed in a liquid medium, creating a homogeneous mixture for easy administration.
Perphenazine is an antipsychotic medication used to treat symptoms of schizophrenia and to control severe nausea and vomiting in adults.
Perphenazine Oral Suspension should be taken exactly as prescribed by your healthcare provider. Shake the bottle well before each use to ensure the medication is evenly mixed. Use a proper measuring device to ensure accurate dosing.
Yes, Perphenazine Oral Suspension can be taken with or without food. However, taking it with food may help reduce stomach upset.
If you miss a dose of Perphenazine Oral Suspension, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to catch up.
Common side effects of Perphenazine may include drowsiness, dizziness, dry mouth, blurred vision, and constipation. If you experience severe side effects such as uncontrolled muscle movements, severe dizziness, or signs of an allergic reaction, seek medical attention immediately.
Store Perphenazine Oral Suspension at room temperature, away from light and moisture. Keep the bottle tightly closed and out of reach of children and pets.
Perphenazine may cause drowsiness or dizziness. Avoid driving or operating heavy machinery until you know how the medication affects you.
The safety and effectiveness of Perphenazine in children have not been established. Consult your healthcare provider for advice specific to pediatric use.
It is advisable to avoid alcohol while taking Perphenazine, as it can increase the risk of side effects such as drowsiness and dizziness.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
